Skip to main content
SpringerLink
Log in

A Review of Quality of Life in Alzheimer’s Disease

Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects

  • Correpondence
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Walker MD, Salek SS, Bayer AJ. A review of quality of life in Alzheimer’s disease. Part 1: issues in assessing disease impact. Pharmacoeconomics 1998; 14 (5): 499–530

    Article  PubMed  CAS  Google Scholar 

  2. Salek SS, Walker MD, Bayer AJ. A review of quality of life in Alzheimer’s disease. Part 2: issues in assessing drug effets. Pharmacoeconomics 1998; 14 (6): 613–27

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Corporate Health Economics, Boehringer Ingelheim, Ingelheim, Germany

    Marianne Greer & Helma Monteban

Authors
  1. Marianne Greer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helma Monteban
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greer, M., Monteban, H. A Review of Quality of Life in Alzheimer’s Disease. Pharmacoeconomics 15, 641 (1999). https://doi.org/10.2165/00019053-199915060-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199915060-00009

Keywords

Search

Navigation